274 related articles for article (PubMed ID: 32399549)
1. Chinese pharmacists' rapid response to the COVID-19 outbreak.
Tan SL; Zhang BK; Xu P
Am J Health Syst Pharm; 2020 Jul; 77(14):1096-1097. PubMed ID: 32399549
[No Abstract] [Full Text] [Related]
2. Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic.
Strand MA; Bratberg J; Eukel H; Hardy M; Williams C
Prev Chronic Dis; 2020 Jul; 17():E69. PubMed ID: 32701431
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-Led Chronic Care Management for Medically Underserved Rural Populations in Florida During the COVID-19 Pandemic.
Como M; Carter CW; Larose-Pierre M; O'Dare K; Hall CR; Mobley J; Robertson G; Leonard J; Tew L
Prev Chronic Dis; 2020 Jul; 17():E74. PubMed ID: 32730199
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak.
Ung COL
Res Social Adm Pharm; 2020 Apr; 16(4):583-586. PubMed ID: 32081569
[TBL] [Abstract][Full Text] [Related]
5. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
[TBL] [Abstract][Full Text] [Related]
6. The role of mental health services during the COVID-19 outbreak in China.
Kang C; Tong J; Meng F; Feng Q; Ma H; Shi C; Yuan J; Yang S; Liu L; Xu L; Xi Y; Li W; Zhao X; Yang J
Asian J Psychiatr; 2020 Aug; 52():102176. PubMed ID: 32470875
[No Abstract] [Full Text] [Related]
7. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.
Cerbin-Koczorowska M; Waszyk-Nowaczyk M; Przymuszała P
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684
[TBL] [Abstract][Full Text] [Related]
8. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.
Zhang J; Lin G; Zeng J; Lin J; Tian J; Li G
J Clin Virol; 2020 May; 126():104341. PubMed ID: 32278300
[TBL] [Abstract][Full Text] [Related]
9. The novel coronavirus (COVID-19) infection in Hangzhou: An experience to share.
Diao M; Zhang S; Chen D; Hu W
Infect Control Hosp Epidemiol; 2020 Jul; 41(7):874-875. PubMed ID: 32131914
[No Abstract] [Full Text] [Related]
10. Dermatology staff participate in fight against Covid-19 in China.
Zheng Y; Lai W
J Eur Acad Dermatol Venereol; 2020 May; 34(5):e210-e211. PubMed ID: 32201983
[No Abstract] [Full Text] [Related]
11. The model of epidemic (COVID-19) prevention and control in rural of China.
Fu B; Fu X
Crit Care; 2020 Apr; 24(1):146. PubMed ID: 32290856
[No Abstract] [Full Text] [Related]
12. As normalcy returns, can China keep COVID-19 at bay?
Normile D
Science; 2020 Apr; 368(6486):18-19. PubMed ID: 32241931
[No Abstract] [Full Text] [Related]
13. Summary of the COVID-19 outbreak in Vietnam - Lessons and suggestions.
Nguyen THD; Vu DC
Travel Med Infect Dis; 2020; 37():101651. PubMed ID: 32247928
[No Abstract] [Full Text] [Related]
14. Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?
Orive G; Lertxundi U; Barceló D
Eur J Epidemiol; 2020 Jun; 35(6):613-614. PubMed ID: 32529510
[No Abstract] [Full Text] [Related]
15. Providing pharmacy services during the coronavirus pandemic.
Liu S; Luo P; Tang M; Hu Q; Polidoro JP; Sun S; Gong Z
Int J Clin Pharm; 2020 Apr; 42(2):299-304. PubMed ID: 32222911
[TBL] [Abstract][Full Text] [Related]
16. The challenge of communicating and controlling the coronavirus epidemic.
Moreno-Montoya J
Biomedica; 2020 Mar; 40(1):11-13. PubMed ID: 32220158
[No Abstract] [Full Text] [Related]
17. Department of rehabilitation medicine in Shanghai response for coronavirus disease 2019: the impact and challenges.
Zhong Z; Zhang J; Chen J; Liu B
Eur J Phys Rehabil Med; 2020 Jun; 56(3):345-346. PubMed ID: 32293815
[No Abstract] [Full Text] [Related]
18. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems.
Abdi M
Infect Control Hosp Epidemiol; 2020 Jun; 41(6):754-755. PubMed ID: 32192541
[No Abstract] [Full Text] [Related]
19. Novel coronavirus pneumonia emergency in Zhuhai: impact and challenges.
Jin H; Liu J; Cui M; Lu L
J Hosp Infect; 2020 Apr; 104(4):452-453. PubMed ID: 32068012
[No Abstract] [Full Text] [Related]
20. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak.
van der Werf S; Peltekian C
Virologie (Montrouge); 2020 Apr; 24(S1):e12-15. PubMed ID: 32186279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
